FOCUS: A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients

Sponsor
Cochlear (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05003674
Collaborator
(none)
30
2
2
18
15
0.8

Study Details

Study Description

Brief Summary

This feasibility study is designed to explore several facets of hearing performance that may show improvements for alternative modes of stimulation compared to Monopolar (MP) stimulation within a group of adult cochlear-implant recipients. Measures of speech recognition, music appreciation, listening effort, quality of life, and real-world assessments will be gathered to determine the most promising benefits for further examination.

Condition or Disease Intervention/Treatment Phase
  • Device: Focused stimulation strategy
  • Device: ACE stimulation strategy
N/A

Detailed Description

Alternative modes of stimulation will be investigated that may improve spectral resolution through reduced cochlear spread of excitation and in turn provide enhanced speech perception and real-world clinical benefits over MP stimulation. The purpose of this feasibility study is to explore several facets of hearing performance that may show improvements with these alternative modes of stimulation compared to MP stimulation within a group of adult cochlear-implant recipients. Measures of speech recognition, music appreciation, listening effort, quality of life, and real-world assessments will be gathered to determine the most promising benefits for further examination. Individual neural, psychophysical, cognitive, and electrode placement data will also be obtained to inform questions related to across-subject variability, and practical aspects of power consumption and device fitting will be evaluated.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Feasibility, Prospective, Multi-centre, Repeated-measures Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adults cochlear implant recipients receiving alternative stimulation strategy

ACE strategy, 8 maxima, alternative mode

Device: Focused stimulation strategy
Investigational focused stimulation strategy

Active Comparator: Adults cochlear implant recipients receiving Standard-of-Care stimulation strategy.

ACE strategy, 8 maxima, monopolar mode.

Device: ACE stimulation strategy
Standard of care stimulation strategy

Outcome Measures

Primary Outcome Measures

  1. Mean difference between stimulation modes for sentence perception in background noise (dB) (AuSTIN) [7 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adults 18 years of age or older.

  2. Candidate for unilateral cochlear implant with Slim Modiolar electrode array as determined by the implanting centre.

  3. English spoken as a primary language.

  4. Willingness to comply with all investigational requirements.

  5. Willing and able to provide written informed consent.

Exclusion Criteria:
  1. Previous or existing cochlear-implant recipient.

  2. Evidence of severe or greater sensorineural hearing loss prior to five years of age.

  3. Open-set pre-operative word score > 70% in the contralateral ear.

  4. Duration of severe to profound hearing loss > 20 years in the ear to be implanted.

  5. Adults with functional acoustic hearing in the ear to be implanted who desire to use an acoustic component in the implanted ear.

  6. Ossification or other cochlear anomaly that might prevent complete insertion of the electrode array.

  7. Hearing loss of neural or central origin.

  8. Medical or psychological conditions that would contraindicate undergoing surgery.

  9. Women who are pregnant.

  10. Additional handicaps that would prevent or restrict participation in the audiological evaluations.

  11. Unrealistic expectations on the part of the subject regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure and prosthetic device.

  12. Inability or unwillingness to use a hand-held device to control the sound processor and to collect test and survey data.

  13. Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.

  14. Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.

  15. Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.

  16. Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Royal Victorian Eye and Ear Hospital East Melbourne Victoria Australia 3002
2 St Vincent's Private Hospital East Melbourne Victoria Australia 3002

Sponsors and Collaborators

  • Cochlear

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cochlear
ClinicalTrials.gov Identifier:
NCT05003674
Other Study ID Numbers:
  • AI5782
First Posted:
Aug 12, 2021
Last Update Posted:
May 6, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cochlear
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2022